[ET Net News Agency, 17 November 2023] JD HEALTH (06618) fell 5.1% to HK$36.6, dipping
below the 20-D SMA of HK$36.8.
It hits an intra-day low of HK$36.6, and an intra-day high of HK$38.15. The total shares
traded was 845,119, with a value of HK$31.55m. The active buy/sell ratio is 38:62, with
net selling turnover of HK$6.32m. CHINA INV INFO accounts for greatest net responsive
buying turnover of HK$3.07m, with volume weighted average price of HK$37.092. CITIGROUP
GLOBAL accounts for greatest net responsive selling turnover of HK$1.6m, with volume
weighted average price of HK$37.443. The stock has fallen a combined 9.3% over the past 2
consecutive trading days.
RMB counter of JD HEALTH (86618) fell 4.9% to RMB34.15. It hits an intra-day low of
RMB34.25, and an intra-day high of RMB35.3. The total shares traded was 1,850, with a
value of RMB63,705.
The Hang Seng Index now fell 286 points, or 1.6% to 17,546; the Hang Seng China
Enterprises Index now fell 106 points, or 1.7% to 6,010; the Hang Seng TECH Index now fell
63 points, or 1.6% to 3,985.
Basic Information
=================
----------------------------------
Nominal 36.600 % Chg -5.06%
High 38.150 Low 36.600
Shares Tr 845,119 Turnover 31.55m
10-D SMA 38.380 %H.V 47.875
20-D SMA 36.800 VWAP 37.327
50-D SMA 38.596 RSI14 44.916
----------------------------------
Status: Dipping below the 20-D SMA, active buy/sell ratio is 38:62, with net selling
turnover of HK$6.32m, falling a combined 9.3% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
JD HEALTH (06618) 36.60 -5.06
ALI HEALTH (00241) 4.57 -6.73
TRAD CHI MED (00570) 3.55 -0.28
CSPC PHARMA (01093) 6.74 -0.44
SINOPHARM (01099) 18.76 -2.39
SINO BIOPHARM (01177) 3.74 -0.53
CHINARES PHARMA (03320) 4.88 -1.01
HANSOH PHARMA (03692) 14.42 -0.14
SCICLONE PHARMA (06600) 11.98 +5.83
JD HEALTH-R (86618) RMB34.15 -4.87
-----------------------------------------------
(ed)